Ledger.Open graph →
SEC Form D · filed January 2, 2018

Centrexion Therapeutics Corp

Offering
$69.6M
Sold
$69.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Arnold Oronsky · BOSTON, MADirectorJeffrey B. Kindler · BOSTON, MAExec · DirectorSol J. Barer · BOSTON, MADirectorRandall M. Stevens · BOSTON, MAExecJames N. Campbell · BOSTON, MAExec · DirectorGregg J. Beloff · BOSTON, MAExecSara J. Nayeem · BOSTON, MADirectorIsaac J. Blech · BOSTON, MADirectorShawn J. Tomasello · BOSTON, MADirectorJennifer L. Carnes · Pittsburgh, PADirectorJulie Hughes · Grand Cayman, Cayman IslandsExec · DirectorMarshawn Govan · Fresno, CAExecArnold Chase · Hartford, CTExec · DirectorScott Dakers · Grand Cayman, Cayman IslandsDirectorLpgp LLC · El Segundo, CAExec · DirectorKWK Management LLC · El Segundo, CADirectorIvana Faltysova · Grand Cayman, Cayman IslandsExec · DirectorKraig Kupiec · El Segundo, CADirectorRoger H. Hanson · Grand Cayman, Cayman IslandsExecGregg J. Beloff · BOSTON, MAExecSara J. Nayeem · BOSTON, MADirectorIsaac J. Blech · BOSTON, MADirectorShawn J. Tomasello · BOSTON, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗